TNFI, methotrexate safe to use in COVID-19 patients
Tumour necrosis factor inhibitors (TNFI) and methotrexate do not appear to worsen outcomes among patients with the novel coronavirus disease (COVID-19), a new study has shown.
TNFI, methotrexate safe to use in COVID-19 patients
25 Dec 2020